Thank you for Subscribing to Med Tech Business Review Weekly Brief
Pre-Analytical Pathology Procurement Beyond Unit Price
Medtech Business Review | Friday, November 06, 2026
Pathology laboratories can absorb a surprising amount of risk from products that look routine on a procurement sheet. A slide, cassette, reagent or printer may carry a low unit cost, yet poor compatibility can disrupt sample identification or staining quality after significant labor has already been invested. Problems may also emerge in tissue preparation or downstream reading. That makes product consistency and workflow compatibility central to evaluating a clinical consumables and equipment manufacturer.
Compatibility deserves close attention because many pre-analytical workflows combine equipment and consumables sourced from different manufacturers. Printers must produce readable labels on the specific slides or cassettes used in the lab, while reagents and processing equipment need to perform consistently across repeated runs. A mismatch may not stop the workflow immediately. It can surface later as weak barcode readability or inconsistent preparation. Buyers should examine whether a manufacturer develops related products together and validates how they interact. Clear performance boundaries and documented use conditions provide additional assurance when laboratories standardize purchasing.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Product breadth can reduce procurement complexity, but only when the portfolio is coherent. Laboratories often need collection and fixation products alongside slides, cassettes, stains, reagents and specialized equipment. A broad catalog is less useful if each item functions as an isolated purchase. More relevant is whether the manufacturer can support connected parts of the pre-analytical process without forcing the lab to reconcile multiple technical standards or service relationships. That becomes especially important for health systems standardizing workflows across several sites.
“StatLab develops both equipment and associated consumables in-house, allowing products such as printers with slides or cassettes to be engineered for compatibility rather than treated as unrelated purchases.”
Specimen identification introduces another layer of risk. Labeling tools and printers must preserve readable information as tissue moves through preparation before diagnosis. Manual handling remains common in anatomical pathology, while specimen variation limits how far laboratories can automate. Equipment that reduces repetitive handling or helps standardize routine steps can improve consistency without demanding a complete workflow redesign. Evaluation should cover traceability and printer-media compatibility, along with integration into existing laboratory processes and the amount of manual intervention still required.
Availability can determine whether a technically suitable product is usable across an organization. Smaller laboratories may buy directly while hospital systems often procure through national distributors under prime vendor contracts. Manufacturers able to support different purchasing routes can reduce friction when procurement arrangements vary between sites. Procurement teams also need to distinguish between nominal product availability and dependable replenishment when daily specimen volumes leave little tolerance for substitutions or delayed deliveries during routine laboratory work cycles. Supply continuity also warrants examination across frequently used consumables and equipment-dependent products. Service access becomes especially relevant when a malfunctioning device or incompatible consumable can interrupt preparation already underway.
StatLab manufactures consumables and equipment across much of the pre-analytical anatomical pathology workflow, including slides, cassettes, reagents, printers, tissue processors and microtomes. The company develops equipment and associated consumables in-house, allowing products such as printers with slides or cassettes to be engineered for compatibility rather than treated as unrelated purchases. Its portfolio also includes labeling and tracking tools intended to support specimen identification through the workflow. StatLab sells directly and through distribution partners, giving laboratories access through different procurement routes. Buyers seeking to consolidate pre-analytical purchasing, improve coordination between equipment and consumables, and meet sample-tracking requirements have the clearest reason to assess StatLab.
More in News
Connected medical products are changing what manufacturers expect from compliance and certification testing labs. A device may now combine electronics, software, patient-contacting materials and data connectivity. Each layer introduces safety questions that cannot be reviewed in isolation.
This shift has made multidisciplinary testing more important. A product team may need evidence for electrical safety, biological evaluation, software behavior and cybersecurity controls. These areas are connected because a change in one part of the product can affect the others. A material change may alter biocompatibility evidence. A software update may affect risk files and the validation scope.
Electrical and electronic medical products often use standards such as IEC 60601-1, which offers wide requirements for basic safety and essential performance. The IEC states that IEC 60601-1 is generally applicable to medical electrical equipment and may be supplemented by collateral or particular standards, depending on the type of device.
Another crucial topic is biological safety. The requirements and general guidelines for assessing biological safety in a risk management procedure are outlined in ISO 10993-1:2025. This approach is important since the type of evidence required can vary depending on patient exposure, duration of use, material interaction, and intended clinical environment.
These streams of evidence must now be coordinated by manufacturers with the assistance of testing labs. Running independent tests is not the only difficulty. It involves ensuring that the outcomes support a logical risk rationale. The manufacturer's understanding of the device as a system rather than a collection of disparate parts is what regulators and certifying bodies want to see.
Additional pressure is added by software-driven products. As cybersecurity standards continue to advance, updates may be made after launch. The definition of product conformity is altered as a result. Processes that can accommodate post-market modifications without eroding safety evidence or producing ambiguous documentation trails are essential for manufacturers.
Technical breadth is necessary for labs that cater to this sector. In addition to having a practical understanding of device creation, they must comprehend test procedures and standards terminology. Products that undergo design revisions might not be compatible with a strict testing protocol. Manufacturers can plan evidence around potential modifications with a more practical approach.
The effect on the business is significant. Delays in one testing domain may affect the entire submission or certification schedule. If manufacturers undervalue this interaction, they can subsequently discover that the evidence is insufficient or erroneous. Products with various uses are especially susceptible to this problem.
Labs that can collaborate across disciplines while maintaining a coherent compliance narrative will be preferred for the next stage of medical product testing. Separate certificates are not enough for connected devices. They need proof that the complete product can function safely in actual clinical settings.
...Read more
Providing compelling evidence of the real-world impact of the technology strengthens the brand's position of Medtech in the market.
Marketing plays a crucial role in the success and longevity of companies in the medical technology industry (Medtech). A well-constructed marketing plan serves as the guiding force, helping medtech firms navigate the intricacies of the market and effectively communicate their value propositions. Before delving into the complexities of a marketing plan, a comprehensive understanding of the medtech landscape is imperative. In order to identify market trends, competitive forces, and regulatory issues, a thorough market analysis is conducted. For a marketing strategy to be successful, industry-specific challenges and opportunities must be recognized.
Every effective marketing plan commences with clearly defined objectives. Whether it involves increasing market share, launching a new product, or establishing thought leadership, having specific and measurable goals provides direction and focus. These objectives must align with the overall business strategy and remain adaptable to the dynamic nature of the MedTech industry. The diverse audience includes healthcare professionals, administrators, patients, and regulatory bodies. The marketing approach is tailored to resonate with each segment. Targeted messages are crafted to address the specific needs and concerns of the audience, showcasing how the technology addresses critical challenges or enhances patient outcomes.
A robust online presence is non-negotiable. A user-friendly website is developed to serve as a comprehensive resource for information about products and the company. Social media platforms are leveraged to engage with the audience, share industry insights, and highlight success stories. A content marketing strategy is implemented to position the brand as a thought leader in the MedTech space. Relationships play a pivotal role in the medtech industry. Cultivating strong connections with healthcare professionals, key opinion leaders, and decision-makers is prioritized. Building credibility and trust requires attending industry conferences, participating in networking events, and collaborating on research initiatives.
Given the stringent regulations governing the medtech sector, a focus on regulatory compliance is essential. The commitment to adhering to industry standards is communicated, and steps taken to ensure the safety and efficacy of products are highlighted. Transparent communication regarding regulatory processes instills confidence in both healthcare professionals and consumers. Data-driven insights are considered invaluable in refining the marketing strategy. Analytics tools are utilized to track the performance of campaigns, monitor customer engagement, and assess the effectiveness of different channels. Continuous analysis allows for timely adjustments, ensuring marketing efforts align with market dynamics and evolving customer preferences.
A strategy is developed for effectively showcasing the clinical validity of products. Case studies are highlighted, research findings are published, and collaborations with reputable institutions for independent validation are emphasized. Innovation becomes the lifeblood of success in a field that experiences rapid advancements. The marketing messaging emphasizes the commitment to continuous improvement and innovation. Emphasis is placed on how the technology stays ahead of the curve, addressing emerging healthcare challenges and consistently improving patient outcomes. Mastering medtech marketing demands a holistic and strategic approach.
...Read more
Amid the ongoing advancements in medical technology and device innovation, the medical industry is also grappling with challenges in medical device packaging, particularly concerning sterility and traceability.
FREMONT , CA : While packaging is essential to ensuring the safety and efficacy of medical devices, recent incidents have underscored the need for enhanced measures to address contamination risks and improve tracking throughout the supply chain.
Sterility is paramount in medical device packaging, as compromised sterility can lead to serious health risks for patients. Several high-profile cases of packaging-related contamination have drawn attention to the vulnerabilities in the current packaging systems. Industry experts have highlighted the importance of adopting stricter quality control processes during the manufacturing and packaging phases to prevent potential contaminants from compromising the integrity of medical devices.
One potential solution gaining traction is using advanced sterilisation methods integrated into the packaging process. Technologies such as gamma irradiation and ethylene oxide gas sterilisation can effectively eliminate microorganisms and contaminants on the packaging surface, enhancing the sterility of the enclosed medical devices. Implementing such methods at the packaging stage can provide additional protection against potential contamination.
Furthermore, the growing complexity of global supply chains has raised concerns about the traceability of medical devices. Tracking the journey of a medical device from manufacturing to end-user has become increasingly challenging, making it difficult to identify the source of any issues that may arise. In response, industry leaders are exploring integrating blockchain technology and unique identifiers, such as QR codes or RFID tags, into medical device packaging.
Blockchain technology, known for its transparency and tamper-proof nature, could enable a secure and unalterable record of a device's journey through the supply chain. This will facilitate quick and accurate recalls if any issues are detected, minimising potential harm to patients and reducing financial losses for manufacturers. Additionally, QR codes and RFID tags could provide real-time information about a device's origin, manufacturing date, and distribution history, improving transparency and accountability.
Regulatory bodies are also stepping up their efforts to address these challenges. They are revising guidelines and standards related to medical device packaging to include more rigorous sterility assurance and traceability requirements. These revisions ensure manufacturers adhere to the highest quality control standards and implement effective tracking mechanisms to safeguard patient safety.
Collaboration across the industry is essential to overcome the medical device sector's packaging challenges. Manufacturers, regulatory authorities, healthcare providers, and technology experts must work together to implement innovative solutions that prioritise sterility, traceability, and patient safety. By leveraging advancements in sterilisation technologies, adopting cutting-edge tracking solutions, and embracing industry-wide best practices; the medical device packaging landscape can evolve to meet the demands of modern healthcare while minimising risks and ensuring patient well-being.
...Read more
Medical product manufacturing in Latin America is encountering a substantial transformation driven by innovation, regulatory alignment, and increasing global demand. The region is becoming an important player in the production of essential medical supplies, devices, and equipment. Local manufacturers are investing in advanced technologies, strengthening compliance standards, and building resilient supply chains. This evolution meets domestic healthcare needs and also positions Latin American firms as competitive suppliers in global markets.
A strong push toward self-sufficiency and healthcare resilience has fueled growth in local manufacturing. Regional governments and industries recognize the need to reduce dependency on imports, particularly during times of global disruption. This shift supports faster delivery, cost savings, and better adaptation to local healthcare demands.
Innovation and Automation Reshape Production
Technology is playing a prominent role in transforming how medical products are made across Latin America. Manufacturers are implementing automation and robotics to streamline production lines, reduce errors, and increase output. These tools help ensure greater consistency in quality and enable faster responses to market needs.
Digital technologies such as AI and data analytics are used to monitor production performance, track compliance, and forecast demand. This shift enables better decision-making and supports real-time improvements. Manufacturers can also respond more efficiently to changing regulations and certification requirements, thereby accelerating product development cycles.
3D printing is gaining traction for producing custom medical devices, prototypes, and replacement parts. It offers flexibility in design and production, especially for small-scale or specialized items. Smart sensors and IoT integration enhance equipment monitoring and maintenance, reducing downtime and extending machine lifecycles.
Investment in research and development is increasing, encouraging collaboration between private manufacturers, research institutes, and healthcare providers. These partnerships foster innovation in areas such as wearable medical devices, remote monitoring tools, and environmentally friendly materials.
Focus on Local Sourcing and Regulatory Alignment
Another key trend is the move toward local sourcing of materials and components. This approach reduces supply chain disruptions, lowers transportation costs, and boosts regional economic development. Manufacturers are building closer relationships with local suppliers and investing in training to improve quality and reliability.
Efforts to align regulatory frameworks across countries are helping streamline approvals and facilitate trade. Harmonization with international standards is also improving access to global markets. Manufacturers benefit from clearer guidelines and faster time-to-market, while patients benefit from quicker access to high-quality products.
Environmental sustainability is also gaining attention, with many companies adopting greener production practices and reducing waste. These efforts improve brand reputation and also align with growing consumer and government expectations for responsible manufacturing.
...Read more
